Nanotechnology‐Mediated Immunomodulation Strategy for Inflammation Resolution
Advanced Healthcare Materials · 2024-10 · 13 (27)
DOI: 10.1002/adhm.202401384 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, online erschienen am 23.07.2024. Verfasst von Ying Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical Engineering and Technology, Tianjin University, Yaguan Road 135, Tianjin, 300350, P. R. China. Hauptthemen laut MEDLINE: Inflammation, Immunomodulation. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 178 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Tianjin Municipal Science and Technology Commission.
Abstract (Originalsprache)
Inflammation serves as a common characteristic across a wide range of diseases and plays a vital role in maintaining homeostasis. Inflammation can lead to tissue damage and the onset of inflammatory diseases. Although significant progress is made in anti‐inflammation in recent years, the current clinical approaches mainly rely on the systemic administration of corticosteroids and antibiotics, which only provide short‐term relief. Recently, immunomodulatory approaches have emerged as promising strategies for facilitating the resolution of inflammation. Especially, the advanced nanosystems with unique biocompatibility and multifunctionality have provided an ideal platform for immunomodulation. In this review, the pathophysiology of inflammation and current therapeutic strategies are summarized. It is mainly focused on the nanomedicines that modulate the inflammatory signaling pathways, inflammatory cells, oxidative stress, and inflammation targeting. Finally, the challenges and opportunities of nanomaterials in addressing inflammation are also discussed. The nanotechnology‐mediated immunomodulation will open a new treatment strategy for inflammation therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Chemical Engineering and Technology, Tianjin University, Yaguan Road 135, Tianjin, 300350, P. R. China.
- Department of Gastroenterology and Hepatology, Characteristic Medical Center of the Chinese People's Armed Police Force, Tianjin Key Laboratory of Hepatopancreatic Fibrosis and Molecular Diagnosis & Treatment, Tianjin,…
- Frontiers Science Center for Synthetic Biology, Tianjin University, Weijin Road 92, Tianjin, 300072, P. R. China.
- Key Laboratory of Systems Bioengineering (Ministry of Education), Tianjin University, Weijin Road 92, Tianjin, 300072, P. R. China.
ORCID-Profile: Yakai Feng
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Tianjin Municipal Science and Technology Commission
Zitieren
APA
Li, Y., Liu, W., Wang, Y., Liu, T., & Feng, Y. (2024). Nanotechnology‐Mediated Immunomodulation Strategy for Inflammation Resolution. Advanced Healthcare Materials, 13(27). https://doi.org/10.1002/adhm.202401384
Vancouver
Li Y, Liu W, Wang Y, Liu T, Feng Y. Nanotechnology‐Mediated Immunomodulation Strategy for Inflammation Resolution. Advanced Healthcare Materials. 2024;13(27). doi:10.1002/adhm.202401384
BibTeX
@article{Li2024,
author = {Li, Ying and Liu, Wen and Wang, Yuanchao and Liu, Taotao and Feng, Yakai},
title = {Nanotechnology‐Mediated Immunomodulation Strategy for Inflammation Resolution},
journal = {Advanced Healthcare Materials},
year = {2024},
volume = {13},
number = {27},
doi = {10.1002/adhm.202401384}
}
EUVIMED